Nature Communications (Nov 2017)

Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation

  • Arif E. Cetin,
  • Mark M. Stevens,
  • Nicholas L. Calistri,
  • Mariateresa Fulciniti,
  • Selim Olcum,
  • Robert J. Kimmerling,
  • Nikhil C. Munshi,
  • Scott R. Manalis

DOI
https://doi.org/10.1038/s41467-017-01593-2
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 12

Abstract

Read online

Multiple myeloma is characterized by high rates of drug resistance and relapse. Here the authors utilize a functional assay to assess the ex vivo drug sensitivity of single multiple myeloma cells based on measuring the mass accumulation rate of individual cells.